HF
IRD

HRT Financial’s Opus Genetics IRD Stock Holding History

HRT Financial’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-67,663
Closed -$307K – 5621
2026
Q1 		$307K Buy
+67,663
New +$234K ﹤0.01% 2858
2025
Q4 		– Sell
-20,677
Closed -$34K – 4257
2025
Q3 		$34K Buy
+20,677
New +$25.7K ﹤0.01% 2644
2025
Q2 		– Sell
-15,168
Closed -$14K – 3733
2025
Q1 		$14K Buy
+15,168
New +$16.9K ﹤0.01% 2332
2024
Q2 		– Sell
-19,868
Closed -$39K – 3278
2024
Q1 		$39K Buy
+19,868
New +$50.4K ﹤0.01% 1957

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HRT Financial's IRD Position: Q2 2026 in Review

HRT Financial sold out of Opus Genetics (IRD) in Q2 2026, closing a stake of 67,663 shares — an estimated $307K sold.

HRT Financial first reported a position in IRD in Q1 2024 and held it in 4 quarters. The position peaked at $307K in Q1 2026. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • HRT Financial reported no remaining Opus Genetics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 67,663 Opus Genetics shares in Q2 2026, an estimated $307K.
  • HRT Financial first reported a position in Opus Genetics in Q1 2024 and held it in 4 quarters.
  • HRT Financial's Opus Genetics position peaked at $307K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.